Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neumora Therapeutics, Inc.

1.02
+0.209925.91%
Post-market: 1.040.0200+1.96%19:59 EDT
Volume:1.84M
Turnover:1.78M
Market Cap:164.98M
PE:-0.63
High:1.05
Open:0.8400
Low:0.8125
Close:0.8101
Loading ...
May 30, 2025

Major Issues Report

Form 8-K - Current report
May 16, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Major Issues Report

Form 8-K - Current report
May 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 11, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 03, 2025

Major Issues Report

Form 8-K - Current report
Feb 21, 2025

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Major Issues Report

Form 8-K - Current report